ANALYSIS OF SOCIODEMOGRAPHIC CHARACTERISTICS OF EARLY AND ADVANCED STAGE CHRONIC KIDNEY DISEASE PATIENTS

Ustun Yılmaz; Selin Kır; Ayca Incı; Nilgun Aksoy; Gulay Demırtas; Semih Gul; Ummuhan Maden

doi:10.53394/akd.981495

Araştırma Makalesi

ERKEN VE İLERİ EVRE KRONİK BÖBREK HASTALARININ SOSYODEMOGRAFİK ÖZELLİKLERİNİN ANALİZİ

Yıl 2021, Cilt: 7 Sayı: 3, 424 - 429, 01.09.2021

Ustun Yılmaz Selin Kır Ayca Incı Nilgun Aksoy Gulay Demırtas Semih Gul Ummuhan Maden

https://doi.org/10.53394/akd.981495

Öz

Objective:It was aimed to investigate sociodemographic features of chronic kidney disease patients, analyze difference of these features in early and advanced stage patients, find correctable factors that may change course of disease and to find new solutions in treatment and follow-up.
Materials & Methods:Predialysis 345 patients diagnosed with chronic kidney disease were retrospectively analyzed. Patients were divided into early and advanced stages. Patients with Glomerular Filtration Rate 30 ml / min were defined as early stage, <30 ml / min as advanced stage. Sociodemographic and disease related features and laboratory parameters of patients were analyzed.
Results:In the study, 243 (70.4%) patients were early stage and 102 (29.6%) patients were advanced stage chronic kidney patients. Most common etiologies are; In early stage, chronic glomerulonephritis (30.5%), diabetes mellitus (16.9%) and genetic diseases (16.0%), while at advanced stage, diabetes mellitus (34.3%), hypertension (16.7%) and unknown causes (15.7%) were. Alcohol use was higher and regular drug use was lower in early stage patients compared to advanced stage patients. In advanced stage patients, habit of exercising regularly was found to be low compared to early stage patients.
Conclusion:It was found that there were correctable factors that could change course of disease. These factors differed in early and advanced stages. It is necessary to be aware of these factors for slower progressive of disease and take precautions for correctable factors from early stages of disease.

Anahtar Kelimeler

Kronik Böbrek Hastalığı, Düzeltilebilir faktörler, Sosyodemografik özellikler

Kaynakça

1. Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 14;379(9811):165-80.
2. Süleymanlar G. Kronik Böbrek Hastalığı ve Yetmezliği: Tanımı, Evreleri ve Epidemiyolojisi. Türkiye Klin J Int Med Sci 2007; 3(38).
3. Süleymanlar G, Utaş C, Arinsoy T, Ateş K, Altun B, Altiparmak MR, Ecder T, Yilmaz ME, Çamsari T, Başçi A, Odabas AR, Serdengeçti K. A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study. Nephrol Dial Transplant 2011; 26(6):1862-71.
4. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Clasification and Stratification. Am J Kidney Dis 2002; 39(2 Suppl 1):S1-266.
5. Hart PD, Bakris GL. Hypertensive nephropathy: prevention and treatment recommendations. Expert Opin Pharmacother 2010; 11(16):2675-86.
6. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Yee-Moon Wang A,Yang CW. Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382(9888):260-72.
7. Naicker S. End-stage renal disease in sub-Saharan and South Africa. Kidney Int Suppl 2003; (83):S119-22.
8. Zeng X, Liu J, Tao S, Hong HG, Li Y, Fu P. Associations between socioeconomic status and chronic kidney disease: a meta-analysis. J Epidemiol Community Health 2018; 72(4):270-279.
9. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150(9):604-12.
10. Bartmańska M, Więcek A. Chronic kidney disease and the aging population. G Ital Nefrol 2016; 33 Suppl 66:33.S66.11.
11. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139(2):137-47.
12. Ryu S, Chang Y, Woo HY, Kim SG, Kim DI, Kim WS, Suh BS, Choi NK, Lee JT. Changes in body weight predict CKD in healthy men. J Am Soc Nephrol 2008; 19(9):1798-805.
13. Mehrotra R, Kopple JD. Nutritional management of maintenance dialysis patients: why aren't we doing better? Annu Rev Nutr 2001; 21: 343-79.
14. Ladi-Akinyemi TW, Ajayi I. Risk factors for chronic kidney disease among patients at oabisi onabanjo university teaching hospital in sagamu, Nigeria: A retrospective cohort study. Malawi Med J 2017; 29(2):166-170.
15. İnci A, Çoban M, Sarıkaya M, Maden Ü. Prediyaliz Kronik Böbrek Hastalarında Kesitsel Bir Çalışma: Yaşam Kalitesi ve Etkileyen Faktörler. Kocatepe Tıp Dergisi 2017; 18:130-135
16. Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol 2006; 164(3):263-71.
17. Taş D, Akyol A. Egzersiz ve Kronik Böbrek Yetmezliği. Türk Nefroloji, Diyaliz ve Transplantasyon Hemşireleri Derneği Nefroloji Hemşireliği Dergisi 2017:1 (12).
18. Kamran A, Sadeghieh Ahari S, Biria M, Malepour A, Heydari H. Determinants of patient’s adherence to hypertension medications: application of health belief model among rural patients. Ann Med Health Sci Res 2014; 4(6):922-7.
19. Yakar B, Demir M. Kronik Böbrek Yetmezliği Olan Hastalarda Antihipertansif İlaç Tedavisine Uyum Oranları ve Etkileyen Faktörlerin Araştırılması. Dicle Tıp Dergisi / Dicle Med J 2019; 46 (4) : 685 - 696.
20. Akpolat T, Utaş C, Süleymanlar G. Nefroloji El Kitabı, 4.baskı. İstanbul: Nobel Tıp Kitabevi, 2007 , sayfa 283-323.